HHS has announced that GHK-Cu is expected to return to Category 1, which would restore compounding access for injectable formulations. BPC-157 On 23 July 2026, PCAC voted to recommend adding BPC-157 to the 503A Bulks List, against FDA staff, who had recommended against listing
Beyond cosmetic changes, many individuals report broader wellness outcomes such as increased energy, improved antioxidant support, and enhanced overall vitality
It should be treated by a dermatologist
We help patients decide whether medications like Wegovy, Zepbound, Ozempic, Mounjaro, Oral Wegovy, or Foundayo make sense for them, and we help patients understand emerging next-generation options such as retatrutide without confusing investigational data with an available prescription
Despite its paramount importance as a fundamental biological compound, glutathione frequently operates in the background, overlooked even by the most diligent health enthusiasts